Brief: Sarepta Therapeutics Announces Commercial Launch Of Elevidys In Japan
24/02/2026 14:10
Sarepta Therapeutics Inc SRPT.O: SAREPTA THERAPEUTICS ANNOUNCES COMMERCIAL LAUNCH OF ELEVIDYS IN JAPAN SAREPTA THERAPEUTICS INC: COMPANY IS ELIGIBLE TO RECEIVE A $40 MILLION MILESTONE PAYMENT UPON FIRST COMMERCIAL SALE IN JAPAN SAREPTA THERAPEUTICS INC - ELEVIDYS AVAILABLE FOR DUCHENNE PATIENTS AGED 3 TO 8 IN JAPAN SAREPTA THERAPEUTICS INC: COMMERCIAL LAUNCH OF ELEVIDYS IN JAPAN BY CHUGAI PHARMACEUTICAL CO., LTD. Source text: ID:nBw9whgx8a Further company coverage: SRPT.O
Recent news on Sarepta Therapeutics
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Sarepta, Dyne fall after Novartis muscle disorder trial failure